Clinical Outcomes Following Stereotactic Ablative Body Radiotherapy to Central Lung Tumours
Julie Duong et al. | Abstract 3080 | ESTRO | 2024
Feasibility of SBRT with CyberKnife in the Scenario of Lung Metastases Re-RT: Monoinstitutional Experience
Esmeralda Scipilliti et al. | Abstract 2749 | ESTRO | 2024
Efficacy and toxicity of moderately hypofractionated radiotherapy via helical TomoTherapy versus conventional radiotherapy combined with concurrent chemotherapy for patients with unresectable stage III non-small cell Lung Cancer: a multicenter, randomized phase III trial Chinese clinical trial registration: ChiCTR1800017367
Huang Wenhan et al. | Abstract 3407 | ESTRO | 2024
Comparison of Clinical Outcomes Between Cone Beam CT-Guided Thermal Ablation and Helical TomoTherapy in Pulmonary Metastases from Hepatocellular Carcinoma
Wang F, Fan S, Shi Q, Zhao D, Sun H, Sothea Y, Wu M, Song H, Chen Y, Cheng J, Zeng Z, Yan Z, He J, Liu L | Front Oncol | 2023
Malignant Pleural Mesothelioma: Preliminary Toxicity Results of Adjuvant Radiotherapy Hypofractionation in a Prospective Trial (MESO-RT)
Parisi E, Arpa D, Ghigi G, Fabbri L, Foca F, Tontini L, Neri E, Pieri M, Cima S, Burgio MA, Belli ML, Luzzi L, Romeo A. | Cancers (Basel) | 2023
Survival and Prognostic Factors of Ultra-Central Tumors Treated with Stereotactic Body Radiotherapy
Salvestrini V, Duijm M, Loi M, Nuyttens JJ | Cancers (Basel) | 2022
Potential Benefit of Dose-Escalated Stereotactic Body Radiation Therapy using CyberKnife for Early-Stage Primary Lung Cancer
Watanabe S, Yamazaki H, Kimoto T, Shiomi H, Yamada K, Suzuki G | Asia Pac J Clin Oncol | 2023
Stereotactic Ablative Body Radiotherapy with w Central High Dose using CyberKnife for Metastatic Lung Tumors
Hayashi K, Suzuki O, Shiomi H, Ono H, Setoguchi A, Nakai M, Nakanishi E, Tatekawa S, Ose N, Hirata T, Tamari K, Seo Y, Funaki S, Isohashi F, Shimizu S, Shintani Y, Ogawa K | BMC Cancer | 2023
Transbronchial Placement of Fiducials within the Lung Tumor Target for SABR Tracking
W Belcher, S Sharma, K Yang, A Ju, J Jung | AAPM | 2023
Thoracic Radiotherapy and Tyrosine Kinase Inhibitors Association: Single-center Preliminary Results
A. Nuccio, M. Torrisi, F.R. Ogliari, L. Giannini, M. Pasetti, A. Fodor, C.R. Gigliotti, C. Fiorino, S. Arcangeli, A.Bulotta, I. Dell’Oca, S. Cascinu, N.G. Di Muzio | PO-1308 | ESTRO | 2023
CT Ventilation Image-guided TomoTherapy at Sparing Functional Lungs for Locally Advanced Lung Cancer
Z. Hou, S. Li, J. Liu, S. Gao, J. Yan | PO-2082 | ESTRO | 2023
Dosimetric and Clinical Aspects of Lung SABR Delivered with Synchrony® Tracking on TomoTherapy
Marzia Cerrato et al | PD-0982 | ESTRO | 2023
Initial Clinical Experience with ITV-free Lung SABR using Synchrony® Tracking on Radixact® TomoTherapy
Fabio Menegatti et al | PO-2001 | ESTRO | 2023
Survival and Prognostic Factors of Ultra-Central Tumors Treated with Stereotactic Body Radiotherapy
Salvestrini V, Duijm M, Loi M, Nuyttens JJ | Cancers (Basel) | 2022
Clinical log data analysis for assessing the accuracy of the CyberKnife fiducial-free lung tumor tracking system
Nakayama M, Nishimura H, Mayahara H | Pract Radiat Oncol | 2018
Correlation and prediction uncertainties in the cyberknife synchrony respiratory tracking system
Pepin EW, Wu H, Zhang Y, Lord B | Med Phys | 2011
Clinical accuracy of the respiratory tumor tracking system of the cyberknife: assessment by analysis of log files
Hoogeman M, Prévost JB, Nuyttens J, Pöll J, Levendag P, Heijmen B. | Int J Radiat Oncol Biol Phys | 2009
Compensation of intrafractional motion for lung stereotactic body radiotherapy (SBRT) on helical TomoTherapy
Price A, Chen J, Chao E, Schnarr E, Schreiber E, Lu L, Cox A, Chang S, Jian J. | Biomed. Phys. Eng. Express | 2019
MyAccuray: Accuray Synchrony® Raises the Bar in AAPM Markerless Lung Target Tracking Challenge
Lee Goddard
Validating Synchrony® on the Radixact® System for Respiratory Motion
John E. Bayouth